Licensing Long-Term Care Facilities Nurses Vaccine 
The Pharma Data
JANUARY 24, 2021
Gritstone Oncology , based in Emeryville, California, announced that it is advancing development of its own second-generation vaccine against COVID-19. It is a virus-based therapeutic vaccine that encodes neoantigens picked by NEC’s Neoantigen Prediction System. The drug was licensed from Immutep Limited. Read on to see.
The Pharma Data
JANUARY 26, 2021
Lilly has received feedback from front-line nurses and doctors administering these infusions regarding the complexity and time requirements for preparation and administration. It remains under review by the FDA. It was identified from a blood sample taken from one of the first U.S. patients who recovered from COVID-19. .
Expert insights. Personalized for you.
52 
Let's personalize your content